INNOCARE

Serial Number 98470424
Registration 7668184
700

Registration Progress

Application Filed
Mar 27, 2024
Under Examination
Approved for Publication
Dec 10, 2024
Published for Opposition
Dec 10, 2024
Registered
Jan 28, 2025

Basic Information

Serial Number
98470424
Registration Number
7668184
Filing Date
March 27, 2024
Registration Date
January 28, 2025
Published for Opposition
December 10, 2024
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 28, 2025
Registration
Registered
Classes
005

Rights Holder

Beijing InnoCare Pharma Tech Co., Ltd.

99
Address
Life Park Road, ZGC Life Science Park
Bldg.8, Community No. 1, No.8 Courtyard
Changping Dist,Beijing 102206
CN

Ownership History

Beijing InnoCare Pharma Tech Co., Ltd.

Original Applicant
99
Changping Dist,Beijing CN

Beijing InnoCare Pharma Tech Co., Ltd.

Owner at Publication
99
Changping Dist,Beijing CN

Beijing InnoCare Pharma Tech Co., Ltd.

Original Registrant
99
Changping Dist,Beijing CN

Legal Representation

Attorney
Dana Stewart-Mekdara

USPTO Deadlines

Next Renewal Deadline
2030 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-28)
Due Date
January 28, 2031
Grace Period Ends
July 28, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

10 events
Date Code Type Description
Jan 28, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 28, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 10, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2024 PUBO A PUBLISHED FOR OPPOSITION
Dec 4, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 17, 2024 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Oct 7, 2024 DOCK D ASSIGNED TO EXAMINER
Oct 7, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 27, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 27, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer

Additional Information

Design Mark
The mark consists of the stylized word INNOCARE.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005